Platelet-activating factor (PAF) is a phospholipid mediator of long-term po
tentiation, synaptic plasticity and memory formation as well as of the deve
lopment of brain damage. In brain, PAF is synthesized by two distinct pathw
ays but their relative contribution to its productions, in various physiolo
gical and pathological conditions, is not established. We have further inve
stigated on the properties of the two enzymes that catalyze the last step o
f the de novo or remodeling pathways in rat brain microsomes, PAF-synthesiz
ing phosphocholinetransferase (PAF-PCT) and lysoPAF acetyltransferase (lyso
PAF-AT), respectively. The latter enzyme is fully active at mu M Ca2+ conce
ntration, inhibited by MgATP and activated by phosphorylation. Because the
reversibility of the reaction catalyzed by PAF-PCT, its direction depends o
n the ratio [CDP-choline]/[CMP], which is related to the energy charge of t
he cell. These and other properties indicate that the de novo pathway shoul
d mainly contribute to PAF synthesis for maintaining its basal levels under
physiological conditions. The remodeling pathway should be more involved i
n the production of PAF during ischemia. During reperfusion, the overproduc
tion of PAF should be the result of the concomitant activation of both path
ways.